Literature DB >> 17346957

Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease.

Fisun Karadag1, Hatice Ozcan, Aslihan B Karul, Mustafa Yilmaz, Orhan Cildag.   

Abstract

Non-thyroidal illness syndrome (NTIS) is frequently detected in chronic, systemic diseases. The objectives of the current study is to assess the alterations of thyroid hormones during exacerbation period, recovery of exacerbation and stable phase of chronic obstructive pulmonary disease (COPD) and correlates of these hormonal alterations. A total of 83 stable COPD patients, 20 patients with acute exacerbation and 30 control subjects were evaluated. TT3, fT3, TT3/TT4 levels of both stable and exacerbation COPD groups were lower than control subjects. TSH was also decreased during exacerbation period. In follow-up of COPD exacerbation group, TSH, TT3, fT3 and TT3/TT4 were found to be increased in measurements on the day of discharge from hospital and after 1 month, compared to baseline values. TT3 and TT3/TT4 were lower in severe COPD; whereas TSH, fT3, TT3 and TT3/TT4 were lower in patients with severe hypoxemia. IL-6 and TNF-alpha were higher in both stable and exacerbation phase COPD groups and IL-6 was correlated to TT3 in stable COPD. As a result, there are significant alterations in thyroid hormones of stable COPD patients, which are related to severity of disease and hypoxemia. The hormonal changes are more significant during exacerbation and partially regress after 1 month when the disease is stabilized. We conclude that COPD patients should not be evaluated for thyroid disease during exacerbation of the disease, and thyroid function alterations during stable phase of the disease should be considered cautiously, since thyroid function abnormalities in non-thyroid illness may mimic or mask biochemical abnormalities observed in true thyroid disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346957     DOI: 10.1016/j.rmed.2007.01.016

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  17 in total

1.  Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Authors:  Fisun Karadag; Aslihan B Karul; Orhan Cildag; Mustafa Yilmaz; Hatice Ozcan
Journal:  Lung       Date:  2008-09-20       Impact factor: 2.584

2.  Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus.

Authors:  Arnaldo Moura Neto; Maria Candida Ribeiro Parisi; Sarah Monte Alegre; Elizabeth Joao Pavin; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.633

3.  Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Justin M Oldham; Disha Kumar; Cathryn Lee; Shruti B Patel; Stephenie Takahashi-Manns; Carley Demchuk; Mary E Strek; Imre Noth
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

4.  Thyroid hormone: a resurgent treatment for an emergent concern.

Authors:  Mason T Breitzig; Matthew D Alleyn; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

Review 5.  A review of the evidence for and against increased mortality in hypothyroidism.

Authors:  Marianne Thvilum; Frans Brandt; Thomas H Brix; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2012-03-06       Impact factor: 43.330

6.  High prevalence of non-thyroidal illness syndrome in patients at long-term care facilities.

Authors:  Joaquin Lado-Abeal; Carmen Diaz; Gilbert Berdine; Kenneth Iwuji; David Araujo-Vilar; Natalia Lampon-Fernandez; Min Wang; Santiago Lojo; Alfonso Rodriguez-Perez; Ana Marcella Rivas
Journal:  Endocrine       Date:  2020-04-28       Impact factor: 3.633

7.  Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.

Authors:  Meytal A Tsadok; Cynthia A Jackevicius; Elham Rahme; Vidal Essebag; Mark J Eisenberg; Karin H Humphries; Jack V Tu; Hassan Behlouli; Jennifer Joo; Louise Pilote
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

8.  Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes.

Authors:  A Moura Neto; M C R Parisi; M A Tambascia; E J Pavin; S M Alegre; D E Zantut-Wittmann
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

9.  COPD and thyroid dysfunctions.

Authors:  Claudio Terzano; S Romani; G Paone; V Conti; F Oriolo
Journal:  Lung       Date:  2013-11-27       Impact factor: 2.584

10.  Can non-thyroid illness syndrome predict mortality in lung cancer patients? A prospective cohort study.

Authors:  Zehra Asuk Yasar; Cenk Kirakli; Ufuk Yilmaz; Zeynep Zeren Ucar; Fahrettin Talay
Journal:  Horm Cancer       Date:  2014-05-16       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.